Price
Financials
Consolidated, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 171 | 167 | 178 | 212 | 218 | 219 | 232 | 258 | 279 | 320 | 342 | 393 |
| Expenses | 126 | 120 | 131 | 158 | 163 | 164 | 175 | 193 | 215 | 246 | 262 | 301 |
| Operating Profit | 46 | 46 | 47 | 54 | 55 | 55 | 57 | 64 | 65 | 74 | 80 | 92 |
| OPM % | 27% | 28% | 26% | 25% | 25% | 25% | 25% | 25% | 23% | 23% | 23% | 23% |
| Other Income | 4 | 5 | 6 | 4 | 3 | 4 | 5 | 9 | 9 | 8 | 7 | 4 |
| Interest | 3 | 0 | 0 | 3 | 2 | 2 | 1 | 0 | 0 | 1 | 5 | 7 |
| Depreciation | 7 | 8 | 8 | 11 | 16 | 17 | 13 | 15 | 19 | 24 | 30 | 28 |
| Profit before tax | 40 | 44 | 44 | 43 | 40 | 40 | 49 | 59 | 55 | 57 | 52 | 61 |
| Tax % | 30% | 33% | 13% | 29% | 23% | 24% | 20% | 28% | 25% | 25% | 14% | 26% |
| Net Profit | 28 | 29 | 38 | 30 | 31 | 30 | 39 | 42 | 41 | 43 | 45 | 45 |
| EPS in Rs | 3.21 | 3.44 | 4.47 | 3.54 | 3.61 | 3.16 | 4.02 | 4.36 | 4.28 | 4.71 | 4.93 | 4.88 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 71 | 78 | 91 | 136 | 215 | 375 | 478 | 635 | 886 | 1,207 | 1,334 |
| Expenses | 53 | 60 | 71 | 98 | 147 | 263 | 343 | 453 | 655 | 902 | 1,024 |
| Operating Profit | 18 | 18 | 20 | 38 | 68 | 112 | 135 | 182 | 230 | 305 | 310 |
| OPM % | 25% | 24% | 22% | 28% | 32% | 30% | 28% | 29% | 26% | 25% | 23% |
| Other Income | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 16 | 11 | 25 | 29 |
| Interest | 6 | 5 | 7 | 20 | 20 | 23 | 23 | 11 | 12 | 19 | 13 |
| Depreciation | 7 | 6 | 8 | 21 | 21 | 28 | 28 | 29 | 57 | 88 | 101 |
| Profit before tax | 5 | 8 | 5 | -2 | 28 | 63 | 88 | 157 | 172 | 224 | 225 |
| Tax % | 41% | 23% | 21% | -18% | 30% | 30% | 25% | 27% | 24% | 24% | |
| Net Profit | 3 | 6 | 4 | -2 | 20 | 44 | 66 | 114 | 131 | 170 | 174 |
| EPS in Rs | 2.21 | 3.75 | 2.43 | -0.79 | 11.09 | 6.74 | 10.04 | 13.33 | 13.55 | 18.20 | 18.80 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 41% | 36% | 44% | ||
| Compounded Profit Growth | % | 57% | 38% | 27% | ||
| Stock Price CAGR | % | % | 43% | 49% | ||
| Return on Equity | 14% | 14% | 12% | 10% |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 16 | 16 | 16 | 16 | 66 | 66 | 86 | 96 | 96 |
| Reserves | 29 | 41 | 39 | 38 | 56 | 51 | 117 | 788 | 1,509 | 1,684 |
| Borrowings | 85 | 125 | 175 | 194 | 193 | 264 | 267 | 85 | 12 | 264 |
| Other Liabilities | 10 | 11 | 26 | 39 | 43 | 45 | 36 | 60 | 114 | 218 |
| Total Liabilities | 138 | 193 | 257 | 287 | 309 | 426 | 486 | 1,019 | 1,731 | 2,262 |
| Fixed Assets | 54 | 53 | 164 | 189 | 251 | 303 | 299 | 442 | 605 | 1,250 |
| CWIP | 64 | 110 | 65 | 62 | 0 | 0 | 0 | 0 | 222 | 102 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 74 | 2 |
| Other Assets | 20 | 30 | 27 | 36 | 58 | 123 | 187 | 577 | 829 | 909 |
| Total Assets | 138 | 193 | 257 | 287 | 309 | 426 | 486 | 1,019 | 1,731 | 2,262 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 25 | 17 | 17 | 39 | 44 | 60 | 64 | -3 | 131 | 205 |
| Cash from Investing Activity | -50 | -51 | -78 | -43 | -21 | -52 | -20 | -226 | -388 | -598 |
| Cash from Financing Activity | 26 | 43 | 47 | 5 | -19 | -1 | -18 | 304 | 509 | 254 |
| Net Cash Flow | 1 | 9 | -13 | 1 | 3 | 7 | 26 | 75 | 253 | -140 |
| Free Cash Flow | 24 | 16 | -60 | -4 | 24 | 21 | 44 | -96 | -171 | -112 |
| CFO/OP | 148% | 103% | 99% | 109% | 67% | 65% | 75% | 22% | 68% | 94% |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 58 | 44 | 48 | 45 | 62 | 83 | 82 | 131 | 124 | 113 |
| Inventory Days | 47 | 42 | 88 | 72 | 43 | 32 | ||||
| Days Payable | 127 | 106 | 490 | 347 | 60 | 171 | ||||
| Cash Conversion Cycle | -22 | -20 | -354 | -229 | 62 | 83 | 82 | 131 | 107 | -26 |
| Working Capital Days | 44 | 29 | -75 | -89 | -18 | 0 | 29 | 118 | 106 | 80 |
| ROCE % | 8% | 6% | 7% | 18% | 26% | 27% | 24% | 14% | 13% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 66.33% | 66.44% | 66.54% | 66.54% | 66.54% | 61.44% | 61.64% | 61.64% | 61.64% | 55.80% | 55.80% | 55.80% |
| FIIs | 5.42% | 2.59% | 3.99% | 4.90% | 6.28% | 9.78% | 4.45% | 4.34% | 6.51% | 6.18% | 5.25% | 5.62% |
| DIIs | 8.88% | 8.81% | 9.30% | 9.40% | 6.97% | 11.50% | 13.56% | 13.52% | 8.71% | 11.02% | 12.00% | 10.84% |
| Public | 19.37% | 22.15% | 20.15% | 19.16% | 20.20% | 17.27% | 20.35% | 20.50% | 23.16% | 27.01% | 26.94% | 27.74% |
| No. of Shareholders | 50,113 | 51,743 | 46,567 | 51,916 | 62,616 | 73,251 | 85,668 | 81,440 | 91,434 | 96,221 | 99,117 | 96,264 |
Fundamentals
Market Cap₹ 10,676 Cr.
Current Price₹ 1,108
Stock P/E58.9
Book Value₹ 185
ROCE12.9 %
ROE10.2 %
Dividend Yield0.05 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)44%
Compounded Profit Growth (TTM)27%
Consolidated figures.
Valuation
Market capRs 9,960 Cr
Enterprise valueRs 9,961 Cr
P/E (TTM)54.98x
Price to book5.59x
Price to sales7.47x
EV / EBITDA29.37x
EV / EBIT41.85x
EV / sales7.47x
Price to cash flow48.70x
Earnings yield1.82%
P/E, 3-year average32.26x
P/B, 3-year average3.34x
P/E, 5-year average32.26x
P/B, 5-year average3.34x
Profitability
Operating margin (excl. other income)25.25%
Operating margin (incl. other income)27.35%
EBITDA margin25.42%
Pre-tax margin16.87%
Net profit margin13.58%
Net margin, latest quarter11.99%
ROE10.36%
ROCE13.24%
ROA8.78%
ROE, 3-year average14.18%
ROCE, 3-year average17.14%
ROA, 3-year average11.16%
ROE, 5-year average26.61%
ROCE, 5-year average20.91%
ROA, 5-year average11.99%
ROIC (approx.)10.18%
Tax rate23.82%
Other income / net worth1.42%
Growth
Sales growth (latest year)36.31%
Profit growth (latest year)34.34%
Sales CAGR, 3 years36.21%
Sales CAGR, 5 years41.18%
Profit CAGR, 3 years38.67%
Profit CAGR, 5 years57.39%
Sales growth QoQ14.96%
Profit growth QoQ-0.97%
Sales growth YoY (latest quarter)52.33%
Profit growth YoY (latest quarter)11.94%
Per share
EPS (TTM)Rs 18.80
EPS (latest year)Rs 18.20
EPS (latest quarter)Rs 4.88
EPS, 3-year averageRs 15.03
EPS, 5-year averageRs 12.37
Book value per shareRs 184.79
Sales per shareRs 138.46
Cash flow per shareRs 21.23
Free cash flow per shareRs -11.62
Efficiency
Asset turnover0.53x
Fixed asset turnover0.97x
Inventory turnover26.77x
Inventory days14 days
Debtor days113 days
Debtors turnover3.22x
Creditor days171 days
Cash conversion cycle-26 days
Working capital days80 days
Leverage
Total debtRs 264 Cr
Cash and bankRs 263 Cr
Net debtRs 1 Cr
Debt to equity0.15x
Net debt / EBITDA0.00x
Interest coverage18.39x
Current ratio (filing 2026-03-31)3.87x
Quick ratio (filing 2026-03-31)3.76x
Trade payables (filing 2026-03-31)Rs 110 Cr
Owners' fund to total sources78.70%
Debt to assets11.67%
Cash flow
Cash from Operating Activity (latest year)Rs 205 Cr
Cash from Investing Activity (latest year)Rs -598 Cr
Cash from Financing Activity (latest year)Rs 254 Cr
Net Cash Flow (latest year)Rs -140 Cr
Free cash flow (latest year)Rs -112 Cr
FCFE (approx.: FCF + change in debt)Rs 140 Cr
Cash from ops / profit, 5 years0.87x
Sales to cash flow5.90x
Statement figures
Net sales (TTM)Rs 1,334 Cr
Net sales (latest year)Rs 1,207 Cr
Sales (latest quarter)Rs 393 Cr
Operating profit excl. other income (latest year)Rs 305 Cr
Operating profit (latest quarter)Rs 92 Cr
Other income (TTM)Rs 29 Cr
EBITDA (TTM)Rs 339 Cr
PBDT (TTM)Rs 326 Cr
Profit before tax (TTM)Rs 225 Cr
Tax (latest year)Rs 53 Cr
Net profit (TTM)Rs 181 Cr
Net profit (latest year)Rs 175 Cr
Net profit (latest quarter)Rs 47 Cr
Depreciation (TTM)Rs 101 Cr
Depreciation (latest quarter)Rs 28 Cr
Interest (TTM)Rs 13 Cr
Cost of goods sold (latest year)Rs 553 Cr
Total expenditure (latest year)Rs 902 Cr
Total income (latest year)Rs 1,233 Cr
Share capitalRs 96 Cr
ReservesRs 1,684 Cr
Shareholders' fundsRs 1,781 Cr
Total assetsRs 2,262 Cr
Net blockRs 1,250 Cr
Capital work in progressRs 102 Cr
InvestmentsRs 2 Cr
ReceivablesRs 375 Cr
InventoryRs 21 Cr
Other liabilitiesRs 218 Cr
Shares outstanding (crore)9.64
Ownership
Promoter holding55.80% (-5.84 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 55.0 is at the 74th percentile of its own 3.2-year range
(median 47.5, low 26.6, high 68.9).
P/B 5.59 is at the 56th percentile (median 5.33).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | YATHARTH | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -10.7% | -2.8% | -7.9 pts |
| 1 month | +6.0% | -6.8% | +12.8 pts |
| 3 months | +19.4% | -7.6% | +27.0 pts |
| 6 months | +67.5% | +0.4% | +67.1 pts |
| 1 year | +32.4% | -9.9% | +42.3 pts |
| 2 years | +80.4% | -13.6% | +94.0 pts |
| 3 years | +173.2% | +14.2% | +159.0 pts |
16 mutual fund schemes hold about ₹933 Cr.
Over three months 1 bought more and 14 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| Bandhan Small Cap Fund | 1.17% | 401 | -20% |
| Kotak Multi Cap Fund | 1.03% | 303 | -10% |
| Kotak Balanced Advantage Fund | 0.64% | 111 | -2% |
| Groww Multicap Fund | 2.19% | 32 | -26% |
| Kotak Special Opportunities Fund | 1.82% | 31 | -16% |
| Kotak Healthcare Fund | 3.25% | 22 | -14% |
| Groww Small Cap Fund | 2.31% | 18 | -29% |
| Motilal Oswal Nifty Microcap 250 Index Fund | 0.45% | 11 | -9% |
| Groww Value Fund(M | 3.25% | 2 | +72% |
| Samco Multi Cap Fund | 0.60% | 1 | -6% |
| Groww Nifty Total Market Index Fund | 0.02% | 0 | -7% |
| Bandhan BSE Healthcare Index Fund | 0.26% | 0 | -7% |
| Angel One Nifty Total Market Index Fund | 0.02% | 0 | -7% |
| Mirae Asset Nifty Total Market Index Fund | 0.02% | 0 | -7% |
| Bandhan Nifty Total Market Index Fund | 0.02% | 0 | -7% |
| Motilal Oswal BSE 1000 Index Fund | 0.02% | 0 | -7% |
Red flags
F-score 6 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹393 Cr +52.3% vs Jun 2025.
Net profit ₹45 Cr +7.1%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 124,503 | 59.2 | 17.4 % |
| Manipal Health Enterprises Ltd | 98,357 | 111 | 12.1 % |
| Max Healthcare Institute Ltd | 95,589 | 63.8 | 14.7 % |
| Aster DM Quality Care Ltd | 63,976 | 177 | 11.6 % |
| Fortis Healthcare Ltd | 62,058 | 58.2 | 13.4 % |
| Global Health Ltd | 38,048 | 66.4 | 17.4 % |
| Narayana Hrudayalaya Ltd | 36,579 | 42.4 | 15.5 % |
| Krishna Institute of Medical Sciences Ltd | 32,336 | 155 | 9.50 % |
| Dr Agarwals Health Care Ltd | 15,701 | 106 | 10.9 % |
| Rainbow Childrens Medicare Ltd | 13,892 | 48.5 | 17.4 % |
| Park Medi World Ltd | 11,898 | 42.8 | 19.5 % |
| Healthcare Global Enterprises Ltd | 10,505 | 218 | 8.30 % |
| Jupiter Life Line Hospitals Ltd | 8,591 | 44.9 | 14.8 % |
| Kovai Medical Center & Hospital Ltd | 6,579 | 25.7 | 22.6 % |
| Artemis Medicare Services Ltd | 5,818 | 50.4 | 14.5 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2026-08-14 | Interim Dividend - Re 0.50 Per Share | |
| 2023-09-21 | Annual General Meeting |
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Scrip PE is greater than 50 (4 trailing quarters)
Quick answers
What is the market cap of Yatharth Hospital & Trauma Care Services Ltd?
Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) has a market capitalisation of Rs 10,676 Cr. at the 2026-10-01 close.
What is the P/E ratio of Yatharth Hospital & Trauma Care Services Ltd?
Yatharth Hospital & Trauma Care Services Ltd trades at a P/E of 58.9 on trailing twelve-month profit, at the 2026-10-01 close.
What were Yatharth Hospital & Trauma Care Services Ltd's latest quarterly results?
In the Jun 2026 quarter, Yatharth Hospital & Trauma Care Services Ltd sales was Rs 393 Cr (+52.3% vs Jun 2025) and net profit was Rs 45 Cr.
What is the 52-week high and low of Yatharth Hospital & Trauma Care Services Ltd?
The 52-week high is Rs 1,184.00 and the 52-week low is Rs 538.25.